Cataract, Epiretinal Membrane, Macular Disease, Rhegmatogenous Retinal Detachment, Vitreomacular Traction, Vitreous Cloudy, Vitreous Hemorrhage
Conditions
Brief summary
Based on the progress of cataract surgery, intraocular lens development, vitreoretinal surgery and anesthesia technology in recent years, the purpose of this study is to develop a new type of more accurate and minimally invasive combined surgery for cataract and fundus diseases, and to evaluate the advantages and value of the surgery as well as related complications, so as to minimize the surgical trauma and obtain faster visual function recovery and better patient comfort. To provide new solutions for the growing demand of eye health care.
Detailed description
To evaluate the efficacy and complications of a new type of minimally invasive femtosecond laser assisted-cataract surgery (FLACS) combined with pars plana vitrectomy (PPV) with two-step anesthesia in the treatment of various common fundus diseases such as rhegmatogenous retinal detachment (RRD), epiretinal membrane (ERM), macular hole (MH), and vitreous opacity, complicated with cataract. It is mainly aimed at the following kinds of common fundus diseases with cataract performing PPV and cataract removal combined with monofocal or premium intraocular lens (IOL) implantation： RRD complicated with cataract: FLACS +PPV + IOL+air; ERM complicated with cataract: FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex; MH complicated with cataract: FLACS + PPV+ IOL + internal limiting membrane peeling + air; Vitreous opacity with cataract: FLACS + PPV+ IOL.
Interventions
PROCEDUREFLACS +PPV+IOL + air
The procedures are combined the FLACS +PPV+IOL + air.
PROCEDUREFLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex
The procedures are combined the FLACS +PPV+IOL + epiretinal membrane peeling + Ozurdex.
PROCEDUREFLACS + PPV+IOL + internal limiting membrane peeling + air
The procedures are combined the FLACS + PPV+IOL + internal limiting membrane peeling + air.
PROCEDUREFLACS + PPV+IOL
The procedures are combined the FLACS + PPV+IOL.
Sponsors
Aier School of Ophthalmology, Central South University
Study design
Allocation
NON_RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
clinical diagnosis of following disease * RRD with cataract * ERM with cataract * MH with cataract * Vitreous opacity with cataract
Exclusion criteria
patients with history of following condition * intraocular surgery * ocular trauma * endophthalmitis * uveitis * glaucoma
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| visual acuity | Change from baseline best-corrected visual acuity at 6 months. | final best-corrected visual acuity |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| complications | through study completion, an average of 6 months. | complications occurred during surgery or post-surgery |
Countries
China
Contacts
Primary ContactJiasong Yang
Backup ContactWensheng Li
Outcome results
None listed